Joseph Sparano
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Leflunomide in Previously Treated Metastatic Triple Negative Cancers (NCT03709446) | Joseph Sparano | 2019-04-16 |
Track Joseph Sparano automatically
Every clearance here is in the API, with alerts when new ones post.